We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
